Design of a generic method for single dual-tracer PET imaging acquisition in clinical routine.


Journal

Physics in medicine and biology
ISSN: 1361-6560
Titre abrégé: Phys Med Biol
Pays: England
ID NLM: 0401220

Informations de publication

Date de publication:
10 04 2023
Historique:
received: 23 12 2022
accepted: 23 03 2023
medline: 11 4 2023
pubmed: 24 3 2023
entrez: 23 3 2023
Statut: epublish

Résumé

Using different tracers in positron emission tomography (PET) imaging can bring complementary information on tumor heterogeneities. Ideally, PET images of different tracers should be acquired simultaneously to avoid the bias induced by movement and physiological changes between sequential acquisitions. Previous studies have demonstrated the feasibility of recovering separated PET signals or parameters of two or more tracers injected (quasi-)simultaneously in a single acquisition. In this study, a generic framework in the context of dual-tracer PET acquisition is proposed where no strong kinetic assumptions nor specific tuning of parameters are required. The performances of the framework were assessed through simulations involving the combination of [

Identifiants

pubmed: 36958048
doi: 10.1088/1361-6560/acc723
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Nasrin Taheri (N)

Nuclear Medicine Department, University Hospital, Nantes, France.
Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Benjamin Le Crom (B)

Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Caroline Bouillot (C)

CERMEP-Life Imaging, Lyon, France.
Lyon Neuroscience Research Center, INSERM U1028/CNRS UMR5292, Lyon, France.

Michel Chérel (M)

Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Nicolas Costes (N)

CERMEP-Life Imaging, Lyon, France.
Lyon Neuroscience Research Center, INSERM U1028/CNRS UMR5292, Lyon, France.

Sébastien Gouard (S)

Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Séverine Marionneau-Lambot (S)

Nuclear Medicine Department, University Hospital, Nantes, France.
Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Thibault Merlin (T)

LaTIM, INSERM, UMR 1101, University of Brest, Brest, France.

Dimitris Visvikis (D)

LaTIM, INSERM, UMR 1101, University of Brest, Brest, France.

Simon Stute (S)

Nuclear Medicine Department, University Hospital, Nantes, France.
Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Thomas Carlier (T)

Nuclear Medicine Department, University Hospital, Nantes, France.
Nantes Université, INSERM, CNRS, Université d'Angers, CRCI2NA, Université de Nantes, Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH